T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity

PURPOSE: Successful tumor eradication primarily depends on generation and maintenance of a large population of tumor-reactive CD8 T cells. Dendritic cells (DCs) are well-known potent antigen-presenting cells and have applied to clinics as potent antitumor therapeutic agents. However, high cost and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang-Eun, Shin, A-Ri, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373873/
https://www.ncbi.nlm.nih.gov/pubmed/32065848
http://dx.doi.org/10.4143/crt.2019.721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373873/
https://www.ncbi.nlm.nih.gov/pubmed/32065848
http://dx.doi.org/10.4143/crt.2019.721

Ejemplares similares